Best TWAS P=2.92e-15 · Best GWAS P=2.67e-13 conditioned to 0.00374
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | ARFRP1 | 0.07 | 0.07 | lasso | 3 | 0.06 | 5.3e-08 | -7.2 | 7.3 | 3.9e-13 | -0.96 | 0.01 | 0.99 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | STMN3 | 0.07 | 0.02 | lasso | 4 | 0.05 | 2.8e-06 | -6.3 | -6.3 | 3.0e-10 | 0.71 | 0.03 | 0.97 | FALSE |
3 | GTEx | Brain Cerebellar Hemisphere | STMN3 | 0.39 | 0.08 | lasso | 5 | 0.22 | 2.1e-06 | -6.3 | -7.9 | 2.9e-15 | 0.65 | 0.19 | 0.53 | TRUE |
4 | GTEx | Brain Cerebellum | STMN3 | 0.33 | 0.12 | lasso | 10 | 0.20 | 1.8e-06 | -5.9 | -7.2 | 5.9e-13 | 0.66 | 0.04 | 0.95 | FALSE |
5 | GTEx | Brain Cortex | STMN3 | 0.25 | 0.09 | lasso | 7 | 0.11 | 6.8e-04 | -6.2 | -6.8 | 7.6e-12 | 0.73 | 0.12 | 0.61 | FALSE |
6 | GTEx | Breast Mammary Tissue (Female) | GMEB2 | 0.36 | 0.06 | lasso | 4 | 0.05 | 1.2e-02 | -6.4 | -5.9 | 3.7e-09 | 0.61 | 0.15 | 0.10 | FALSE |
7 | GTEx | Cells Transformed fibroblasts | CTD-3184A7.4 | 0.09 | 0.00 | enet | 28 | 0.00 | 1.4e-01 | -5.1 | -6.0 | 1.5e-09 | 0.49 | 0.02 | 0.87 | FALSE |
8 | GTEx | Esophagus Muscularis | GMEB2 | 0.11 | 0.02 | enet | 30 | 0.00 | 4.5e-01 | -6.3 | -5.3 | 1.5e-07 | 0.36 | 0.08 | 0.39 | FALSE |
9 | GTEx | Pituitary | STMN3 | 0.43 | 0.00 | enet | 8 | 0.06 | 1.1e-02 | -3.1 | -6.3 | 3.5e-10 | 0.55 | 0.05 | 0.32 | FALSE |
10 | GTEx | Testis | RTEL1 | 0.19 | 0.06 | lasso | 5 | 0.14 | 8.0e-07 | -6.2 | -7.1 | 9.8e-13 | 0.62 | 0.17 | 0.66 | FALSE |
11 | GTEx | Thyroid | SLC2A4RG | 0.12 | 0.06 | lasso | 5 | 0.04 | 2.4e-04 | -6.1 | 5.6 | 1.8e-08 | -0.74 | 0.19 | 0.75 | FALSE |
12 | GTEx | Whole Blood | STMN3 | 0.10 | 0.00 | lasso | 3 | 0.00 | 1.2e-01 | -6.5 | 6.5 | 5.8e-11 | -0.73 | 0.02 | 0.81 | FALSE |
13 | METSIM | Adipose | DNAJC5 | 0.03 | 0.00 | blup | 201 | 0.01 | 2.0e-02 | -4.1 | -5.4 | 5.9e-08 | 0.60 | 0.08 | 0.42 | FALSE |
14 | METSIM | Adipose | RTEL1 | 0.07 | 0.01 | enet | 15 | 0.03 | 9.2e-06 | -6.7 | 5.9 | 3.2e-09 | -0.44 | 0.08 | 0.90 | FALSE |
15 | METSIM | Adipose | STMN3 | 0.20 | 0.08 | enet | 30 | 0.11 | 1.0e-16 | -6.2 | 6.7 | 2.9e-11 | -0.43 | 0.91 | 0.09 | FALSE |
16 | METSIM | Adipose | TPD52L2 | 0.03 | 0.00 | bslmm | 207 | 0.02 | 1.5e-03 | 3.3 | 5.9 | 2.9e-09 | -0.68 | 0.02 | 0.75 | FALSE |
17 | YFS | Blood | LIME1 | 0.12 | 0.19 | enet | 15 | 0.19 | 5.3e-59 | -7.1 | -7.4 | 1.1e-13 | 0.98 | 0.01 | 0.99 | FALSE |
18 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | STMN3 | 0.02 | 0.02 | blup | 43 | 0.02 | 1.7e-03 | -6.2 | -5.7 | 1.0e-08 | 0.63 | 0.02 | 0.76 | FALSE |
19 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | TNFRSF6B | 0.03 | 0.01 | blup | 44 | 0.02 | 7.1e-04 | -6.1 | -5.7 | 1.4e-08 | 0.75 | 0.05 | 0.82 | FALSE |
20 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | SLC2A4RG | 0.03 | 0.01 | blup | 48 | 0.02 | 2.4e-03 | -6.1 | 5.8 | 8.2e-09 | -0.69 | 0.06 | 0.50 | FALSE |
21 | The Cancer Genome Atlas | Brain Lower Grade Glioma | LIME1 | 0.02 | 0.03 | blup | 47 | 0.02 | 6.2e-03 | -6.2 | -6.3 | 2.7e-10 | 0.84 | 0.04 | 0.50 | FALSE |
22 | The Cancer Genome Atlas | Lung Adenocarcinoma | TNFRSF6B | 0.02 | 0.01 | enet | 7 | 0.01 | 6.9e-03 | -6.1 | -7.1 | 1.4e-12 | 0.93 | 0.02 | 0.89 | FALSE |
23 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | RTEL1 | 0.05 | 0.04 | blup | 56 | 0.03 | 4.2e-03 | -6.1 | -7.7 | 1.9e-14 | 0.88 | 0.01 | 0.80 | FALSE |
24 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | TNFRSF6B | 0.05 | 0.02 | blup | 44 | 0.03 | 2.9e-03 | -7.3 | -7.3 | 2.5e-13 | 0.93 | 0.01 | 0.75 | FALSE |
25 | The Cancer Genome Atlas | Prostate Adenocarcinoma | ARFRP1 | 0.03 | 0.02 | lasso | 2 | 0.02 | 1.2e-03 | -7.2 | 7.2 | 5.0e-13 | -0.98 | 0.01 | 0.97 | FALSE |
26 | The Cancer Genome Atlas | Prostate Adenocarcinoma | LIME1 | 0.04 | 0.05 | blup | 47 | 0.05 | 9.0e-06 | -7.3 | -6.8 | 1.0e-11 | 0.97 | 0.01 | 0.99 | FALSE |
27 | The Cancer Genome Atlas | Prostate Adenocarcinoma | SLC2A4RG | 0.05 | 0.01 | blup | 48 | 0.02 | 2.0e-03 | -7.3 | 6.7 | 2.2e-11 | -0.85 | 0.01 | 0.95 | FALSE |
28 | The Cancer Genome Atlas | Prostate Adenocarcinoma | ZGPAT | 0.05 | 0.06 | lasso | 3 | 0.06 | 5.5e-07 | -6.3 | 6.8 | 1.5e-11 | -0.83 | 0.05 | 0.95 | FALSE |
29 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | LIME1 | 0.10 | 0.02 | blup | 47 | 0.04 | 1.5e-02 | -7.3 | -6.6 | 3.2e-11 | 0.90 | 0.01 | 0.64 | FALSE |
30 | The Cancer Genome Atlas | Thyroid Carcinoma | ARFRP1 | 0.04 | 0.00 | blup | 51 | 0.00 | 1.3e-01 | -7.1 | 6.8 | 1.4e-11 | -0.81 | 0.01 | 0.58 | FALSE |
31 | The Cancer Genome Atlas | Thyroid Carcinoma | LIME1 | 0.05 | 0.03 | blup | 47 | 0.04 | 3.9e-05 | -6.0 | -6.1 | 1.4e-09 | 0.81 | 0.05 | 0.94 | FALSE |